Medicare Enrolled
Dr. Andrew Jackson, MD
Internal Medicine · Shenandoah, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Jackson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jackson?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Jackson
Dr. Andrew Jackson is an internal medicine specialist in Shenandoah, TX, with 13 years of NPI registration. Based on federal Medicare data, Dr. Jackson performed 100,867 Medicare services across 1,691 unique beneficiaries.
Between the years covered by Open Payments, Dr. Jackson received a total of $17,192 from 23 pharmaceutical and/or device companies across 67 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Jackson is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice
▲ Top 0% volume in TX
$17,192 industry payments
Medicare Practice Summary
Medicare Utilization ↗100,867
Medicare services
Top 0% in TX for internal medicine
1,691
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~7,759 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
43,350 | $0 | $5 |
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
21,600 | $0 | $2 |
| Paclitaxel chemotherapy injection | 12,906 | $0 | $8 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
9,150 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 7,000 | $43 | $136 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,272 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
998 | $8 | $36 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
684 | $90 | $368 |
| Anti-nausea injection (Aloxi/palonosetron) | 680 | $1 | $114 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
438 | $10 | $64 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
425 | $2 | $300 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
357 | $8 | $20 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
232 | $94 | $707 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
229 | $11 | $108 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
157 | $21 | $157 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
153 | $10 | $96 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
144 | $47 | $313 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
115 | $21 | $161 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
113 | $118 | $565 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
111 | $35 | $143 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
95 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
95 | $6 | $34 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
90 | $48 | $344 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
84 | $1 | $7 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
84 | $7 | $431 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
56 | $24 | $256 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
53 | $60 | $250 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
53 | $1 | $8 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
47 | $2 | $19 |
| Lactated Ringer's infusion, up to 1000 cc Intravenous administration of Lactated Ringer's solution, a fluid used to replace fluids and electrolytes, in amounts up to 1000 cubic centimeters. |
35 | $2 | $31 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
34 | $17 | $114 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
16 | $10 | $75 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
11 | $25 | $247 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
43.7% high complexity
53.2% medium
3.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$17,192
Total received (2018-2024)
Avg $3,438/year across 5 years
Top 5% in TX for internal medicine
23
Companies
67
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$16,161 (94.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,031 (6.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$7,618
2023
$8,712
2022
$55
2020
$127
2018
$680
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Alexion Pharmaceuticals, Inc.
$14,002
Genmab U.S., Inc.
$2,159
PFIZER INC.
$195
Novartis Pharmaceuticals Corporation
$169
Celgene Corporation
$144
Straumann USA LLC
$127
Eisai Inc.
$60
AstraZeneca Pharmaceuticals LP
$38
TESARO, Inc.
$33
Bayer HealthCare Pharmaceuticals Inc.
$31
EMD Serono, Inc.
$27
Sirtex Medical Inc
$25
Otsuka America Pharmaceutical, Inc.
$23
Jazz Pharmaceuticals Inc.
$20
SpringWorks Therapeutics, Inc.
$19
Astellas Pharma US Inc
$19
Myriad Genetic Laboratories, Inc.
$17
BTG International, Inc.
$16
Incyte Corporation
$15
Radius Health, Inc.
$14
ABBVIE INC.
$14
Genentech USA, Inc.
$12
Lilly USA, LLC
$12
Top 3 companies account for 95.1% of total payments
Associated products mentioned in payments ›
AFINITOR · Abraxane · Bavencio · CHANTIX · CRESEMBA · CYRAMZA · Epkinly · Halaven · IBRANCE · IMBRUVICA · IMFINZI · JAKAFI · Lenvima · MYLOTARG · Nubeqa · OGSIVEO · Perjeta · Pomalyst · Revlimid · SANDOSTATIN LAR · SCEMBLIX · SIR-Spheres Microspheres · SPRYCEL · SUTENT · Tymlos · ULTOMIRIS · VORAXAZE · VOTRIENT · VYXEOS · Xofigo · ZEJULA · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (94%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 5% for internal medicine in TX.
Equivalent to $17 per 100 Medicare services performed
Geographic Context
Internal medicine physicians within 10 mi
711
Per 100K population
108.6
County median income
$97,266
Nearest hospital
HOUSTON METHODIST THE WOODLANDS HOSPITAL
4.2 mi
4.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Jackson is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), with consulting-driven industry engagement in the top 5% of TX peers.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Jackson experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Jackson performed 43,350 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jackson receive payments from pharmaceutical companies?
Yes. Dr. Jackson received a total of $17,192 from 23 companies across 67 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jackson's costs compare to other internal medicine physicians in Shenandoah?
Dr. Jackson's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jackson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Shenandoah
Browse internal medicine physicians in Shenandoah ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
By company
Genmab U.S., Inc. Payments to Doctors
See all physicians who received payments from Genmab U.S., Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology